Home Cart 0 Sign in  
X

[ CAS No. 33282-16-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 33282-16-5
Chemical Structure| 33282-16-5
Chemical Structure| 33282-16-5
Structure of 33282-16-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 33282-16-5 ]

Related Doc. of [ 33282-16-5 ]

Alternatived Products of [ 33282-16-5 ]

Product Details of [ 33282-16-5 ]

CAS No. :33282-16-5 MDL No. :MFCD02130994
Formula : C11H9NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :YIQABFVYNGOELP-UHFFFAOYSA-N
M.W : 219.19 Pubchem ID :1090978
Synonyms :

Calculated chemistry of [ 33282-16-5 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.09
Num. rotatable bonds : 3
Num. H-bond acceptors : 5.0
Num. H-bond donors : 1.0
Molar Refractivity : 55.39
TPSA : 72.56 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.28 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.56
Log Po/w (XLOGP3) : 1.91
Log Po/w (WLOGP) : 2.05
Log Po/w (MLOGP) : 0.76
Log Po/w (SILICOS-IT) : 1.77
Consensus Log Po/w : 1.61

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.71
Solubility : 0.424 mg/ml ; 0.00194 mol/l
Class : Soluble
Log S (Ali) : -3.06
Solubility : 0.192 mg/ml ; 0.000877 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.27
Solubility : 0.119 mg/ml ; 0.000543 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.56

Safety of [ 33282-16-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 33282-16-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 33282-16-5 ]

[ 33282-16-5 ] Synthesis Path-Downstream   1~21

  • 4
  • [ 425609-97-8 ]
  • [ 33282-16-5 ]
YieldReaction ConditionsOperation in experiment
With lithium hydroxide; In 1,4-dioxane; water; at 20℃; General procedure: Phenylisoxazole ester 9a and 9b or phenylpyrazole ester 9c and 9d (1 mmol) was dissolved in 40 mL 1,4-dioxane, and then 1 N LiOH (3 mL) was added, followed by stirring at room temperature overnight. Next, the mixture was concentrated, and the residue was taken up to 20 mL with water and extracted with EtOAc (30 mL). Subsequently, 2 N HCl was added to the aqueous layer to precipitate the carboxylic acid. The mixture was extracted with DCM (30 mL × 2), dried over Na2SO4 and then evaporated to produce the desired compound (10a-d) as indicated. The yields of the hydrolysis are in the range of 88% to 96%.
  • 5
  • [ 33282-16-5 ]
  • [ 155252-35-0 ]
  • [ 1416981-47-9 ]
YieldReaction ConditionsOperation in experiment
87% With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 0 - 20℃; General procedure: To a solution of compound 15 (1.0 mmol) in dichloromethane (20 ml) was added EDCI·HCl (1.2 mmol) and HOBt (0.1 mmol). Then added corresponding hetroaromatic acids 10a-i, 14a-i and 12a-d (1.0 mmol) and the reaction mixture was stirred at room temperature for 10 h. The reaction was monitored by TLC. After completion of reaction, water was added to reaction mixture and extracted with dichloromethane (2 × 30 ml). The solvent was evaporated under reduced pressure to afford the crude product which was further purified by column chromatography on silica gel using ethyl acetate and hexane as solvent system to obtain the pure products as solids.
  • 6
  • [ 33282-16-5 ]
  • C23H30N2O3 [ No CAS ]
  • 7
  • [ 33282-16-5 ]
  • C11H8ClNO3 [ No CAS ]
  • 8
  • [ 33282-16-5 ]
  • [ 1391625-30-1 ]
  • [ 1391626-10-0 ]
  • 9
  • [ 33282-16-5 ]
  • [ 18978-78-4 ]
  • 5-(4-methoxyphenyl)-N-(2-methylquinolin-8-yl)isoxazole-3-carboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
[00419] 5-(4-Methoxyphenyl)isoxazole-3-carboxylic acid (219 mg, 1.0 mmol) and N-(3- dimethylaminopropyl)-N?-ethylcarbodiimide hydrochloride (230 mg, 1.2 mmol) were dissolved in dimethylformamide (5 mL). N,N-Diisopropylethylamine (260 jiL, 1.5 mmol) was added and the solution was stirred for 10 minutes. To this solution was added 8-aminoquinaldine (158 mg, 1.0 mmol) and the mixture was stirred for 20 hrs. The mixture was diluted with water and extracted with 2 volumes of ethyl acetate. The organic layers were collected and the solvent was removed by rotary evaporation. The residue was purified by preparative reverse-phase HPLC using a water-acetonitrile gradient to afford compound A24. ESI-MS: m/z 360 [M+H].
5-(4-Methoxyphenyl)isoxazole-3-carboxylic acid (219 mg, 1.0 mmol) and N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (230 mg, 1.2 mmol) were dissolved in dimethylformamide (5 mL). N,N-Diisopropylethylamine (260 muL, 1.5 mmol) was added and the solution was stirred for 10 minutes. To this solution was added 8-aminoquinaldine (158 mg, 1.0 mmol) and the mixture was stirred for 20 hrs. The mixture was diluted with water and extracted with 2 volumes of ethyl acetate. The organic layers were collected and the solvent was removed by rotary evaporation. The residue was purified by preparative reverse-phase HPLC using a water-acetonitrile gradient to afford compound A24. ESI-MS: m/z 360 [M+H]+.
  • 10
  • [ 86069-36-5 ]
  • [ 33282-16-5 ]
YieldReaction ConditionsOperation in experiment
75% With 1-hydroxy-3H-benz[d][1,2]iodoxole-1,3-dione; In chloroform; for 4h;Reflux; Green chemistry; General procedure: Ketoxime 5a (0.161 g, 1 mmol), IBX (0.840 g, 3 mmol), and chloroform (5 mL) were placed in a 100 mL round-bottom flask. The reaction was refluxed for 4 h. The reaction was continuously monitored using TLC. The product 6a was purified using column chromatography with petroleum ether and ethyl acetate (9:1) as an eluent.
  • 11
  • [ 943-88-4 ]
  • [ 33282-16-5 ]
  • 12
  • [ 33282-16-5 ]
  • [ 56-17-7 ]
  • N,N'-(disulfanediylbis(ethane-2,1-diyl))bis(5-(4-methoxyphenyl)isoxazole-3-carboxamide) [ No CAS ]
YieldReaction ConditionsOperation in experiment
44% With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine; In tetrahydrofuran; dimethyl sulfoxide; at 20℃; for 24h;Cooling with ice; General procedure: To a solution of oximic acid (4a-k, 3.6 mmol in 50 mL THF) was added HOBt (3.6 mmol) in an ice-cooled bath. Next, a mixture of cystamine dihydrochloride (1.8 mmol) and TEA (1 mL) in DMSO (6 mL) were added, followed by the addition of EDCI (4.0 mmol). After stirring for 24 h at room temperature, the reaction was quenched with water and extracted with EtOAc (60 mL × 3). The combined organic extracts were washed with brine (50 mL), dried over MgSO4 and then evaporated. The resulting residue was then purified by column chromatography on silica gel as indicated.
  • 13
  • Sodium; (Z)-1-methoxycarbonyl-3-(4-methoxy-phenyl)-3-oxo-propen-1-olate [ No CAS ]
  • [ 33282-16-5 ]
  • 14
  • [ 33282-16-5 ]
  • [ 33282-15-4 ]
YieldReaction ConditionsOperation in experiment
With boron tribromide; In dichloromethane; at -20 - 20℃; for 24h;Inert atmosphere; General procedure: To a solution of phenylisoxazole acid or phenylpyrazole acid (10a, 10c and 10d) (1 mmol in 30 mL DCM)was added tribromoborane (3 mmol) dropwise under nitrogen at -20C. After the addition, the solution was stirred at room temperature for 24 h. Next, water was added dropwise to this solution until no gas was liberated. The reaction mixture was then extracted with DCM (20 mL × 2). The organic layer was washed with brine (30 mL × 2), dried over Na2SO4 and concentrated to obtain a crude demethylated product 10e-g (28% to 49% yields).
  • 15
  • [ 33282-16-5 ]
  • N,N'-(disulfanediylbis(ethane-2,1-diyl))bis(5-(4-hydroxyphenyl)isoxazole-3-carboxamide) [ No CAS ]
  • 16
  • [ 33282-16-5 ]
  • 1-isopropyl-1H-pyrazolo [3, 4-d] pyrimidine-3, 4-diamine [ No CAS ]
  • N-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-5-(4-methoxyphenyl)isoxazole-3-carboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
50% General procedure: To a solution of aryl or alkyl acid (1 equiv) in CH2Cl2 (10 mL), was added oxalyl chloride (2.5 equiv) and DMF (0.01 equiv) at 0C and then stirring for 2h. To the resulting solid were added THF (10 mL) and 20 (1.2 equiv) after concentrating under reduced pressure, subsequent cooling to -10C, DIPEA (2.5 equiv) was added dropwise, and the reaction proceed for 3 h. The mixture was added H2O and extracted with chloroform. The combined organic layers were dried over MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by flash column chromatography on silica gel (MeOH/DCM=30/1) to afford the corresponding product.
  • 17
  • [ 33282-16-5 ]
  • [ 61-54-1 ]
  • N-(2-(1H-indol-3-yl)ethyl)-5-(4-methoxyphenyl)isoxazole-3-carboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
76% General procedure: A solution of compound 2 (1 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI) (0.21 g, 1.1 mmol) and hydroxybenzotriazole (HOBt) (0.13 g, 1 mmol) in dry acetonitrile (10 mL) was stirred at room temperature for 30 min. Then, tryptamine 3 (0.16 g, 1 mmol) was added to the mixture and the reaction was continued at room temperature for 24 h. After completion of reaction, the solvent was reduced under vacuum at 40 C and the residue was dissolved in dichloromethane (50%) and washed with sodium carbonate (10%). The organic phase was dried over Na2SO4 and the solvent was evaporated. The obtained compound 4a-k was completely pure.
  • 18
  • [ 925006-96-8 ]
  • [ 33282-16-5 ]
  • 19
  • [ 35322-20-4 ]
  • [ 33282-16-5 ]
  • 20
  • [ 33282-16-5 ]
  • [ 3731-52-0 ]
  • C17H15N3O3 [ No CAS ]
YieldReaction ConditionsOperation in experiment
General procedure: A solution of isoxazole acid derivative 1 (1mmol), EDCI (1.1mmol), and HOBt (1mmol) in dry acetonitrile (10mL) was stirred at room temperature for 30min. Then, 3-picolylamine 2a or 4-picolylamine 2b (1mmol) was added drop wise to the mixture and the reaction was continued at room temperature for 24h. After completion of the reaction, the solvent was reduced under vacuum and the residue was dissolved in dichloromethane and washed with sodium carbonate (10%, 3×20). The organic phase was dried over Na2SO4 and the solvent was evaporated under vacuum to give compound 3 which was completely pure. Finally, the mixture of compound 3 (1mmol) and benzyl halide derivative 4 (1.2mmol) in dry acetonitrile (10mL) was heated at reflux for 10-15h. After completion of the reaction which was monitored by TLC, the mixture was allowed to be cool and the precipitates were filtered off to afford products 5a-q in good yields.
  • 21
  • [ 33282-16-5 ]
  • [ 3731-52-0 ]
  • 3-((5-(4-methoxyphenyl)isoxazole-3-carboxamido)methyl)-1-(2-methylbenzyl)pyridin-1-ium bromide [ No CAS ]
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 33282-16-5 ]

Aryls

Chemical Structure| 14441-90-8

[ 14441-90-8 ]

5-Phenylisoxazole-3-carboxylic acid

Similarity: 0.93

Chemical Structure| 925006-96-8

[ 925006-96-8 ]

Ethyl 5-(4-methoxyphenyl)isoxazole-3-carboxylate

Similarity: 0.92

Chemical Structure| 51677-09-9

[ 51677-09-9 ]

Methyl 5-phenylisoxazole-3-carboxylate

Similarity: 0.89

Chemical Structure| 517870-15-4

[ 517870-15-4 ]

Methyl 5-(4-bromophenyl)isoxazole-3-carboxylate

Similarity: 0.81

Chemical Structure| 745078-74-4

[ 745078-74-4 ]

Methyl 5-(3-bromophenyl)isoxazole-3-carboxylate

Similarity: 0.80

Ethers

Chemical Structure| 925006-96-8

[ 925006-96-8 ]

Ethyl 5-(4-methoxyphenyl)isoxazole-3-carboxylate

Similarity: 0.92

Chemical Structure| 78967-07-4

[ 78967-07-4 ]

2-(3,4-Bis(4-methoxyphenyl)isoxazol-5-yl)acetic acid

Similarity: 0.80

Chemical Structure| 179162-55-1

[ 179162-55-1 ]

4-(5-(4-(Pentyloxy)phenyl)isoxazol-3-yl)benzoic acid

Similarity: 0.77

Chemical Structure| 618383-47-4

[ 618383-47-4 ]

3-(4-Methoxyphenyl)isoxazole-5-carboxylic acid

Similarity: 0.69

Chemical Structure| 325744-41-0

[ 325744-41-0 ]

5-(Chloromethyl)-3-(4-methoxyphenyl)isoxazole

Similarity: 0.66

Carboxylic Acids

Chemical Structure| 14441-90-8

[ 14441-90-8 ]

5-Phenylisoxazole-3-carboxylic acid

Similarity: 0.93

Chemical Structure| 98434-06-1

[ 98434-06-1 ]

5-(Furan-2-yl)isoxazole-3-carboxylic acid

Similarity: 0.83

Chemical Structure| 28691-47-6

[ 28691-47-6 ]

Benzo[d]isoxazole-3-carboxylic acid

Similarity: 0.82

Chemical Structure| 78967-07-4

[ 78967-07-4 ]

2-(3,4-Bis(4-methoxyphenyl)isoxazol-5-yl)acetic acid

Similarity: 0.80

Chemical Structure| 110256-15-0

[ 110256-15-0 ]

5-Cyclopropylisoxazole-3-carboxylic acid

Similarity: 0.78

Related Parent Nucleus of
[ 33282-16-5 ]

Isoxazoles

Chemical Structure| 14441-90-8

[ 14441-90-8 ]

5-Phenylisoxazole-3-carboxylic acid

Similarity: 0.93

Chemical Structure| 925006-96-8

[ 925006-96-8 ]

Ethyl 5-(4-methoxyphenyl)isoxazole-3-carboxylate

Similarity: 0.92

Chemical Structure| 51677-09-9

[ 51677-09-9 ]

Methyl 5-phenylisoxazole-3-carboxylate

Similarity: 0.89

Chemical Structure| 98434-06-1

[ 98434-06-1 ]

5-(Furan-2-yl)isoxazole-3-carboxylic acid

Similarity: 0.83

Chemical Structure| 517870-15-4

[ 517870-15-4 ]

Methyl 5-(4-bromophenyl)isoxazole-3-carboxylate

Similarity: 0.81